Comparison of overall survival between the early use and delayed use of Trastuzumab therapy groups: a retrospective analysis of 128 patients with HER-2-positive advanced breast cancer. [electronic resource]
Producer: 20120823Description: 39-47 p. digitalISSN:- 1559-131X
- Adult
- Aged
- Antibodies, Monoclonal, Humanized -- administration & dosage
- Antineoplastic Agents -- administration & dosage
- Breast Neoplasms -- drug therapy
- Disease-Free Survival
- Female
- Humans
- Kaplan-Meier Estimate
- Middle Aged
- Odds Ratio
- Receptor, ErbB-2 -- biosynthesis
- Retrospective Studies
- Trastuzumab
No physical items for this record
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.